Darimont C, Saint-Marc P, Ailhaud G, Négrel R
Centre de Biochimie, UMR 134, Centre National de la Recherche Scientifique, Université de Nice-Sophia Antipolis, Faculté des Sciences, Parc Valrose, France.
Am J Physiol. 1996 Oct;271(4 Pt 1):E631-5. doi: 10.1152/ajpendo.1996.271.4.E631.
Changes in blood flow induced by the beta-adrenoceptor agonist isoproterenol (Iso) and a stable analogue of the major metabolite of arachidonic acid in adipose tissue, carbaprostacyclin (cPGI2), have been studied in rat periepididymal fat pad with in situ microdialysis measuring the distribution ratio of 0.2% ethanol in the dialysate (outflow) to that in the perfusate (inflow) (O/I ratio). Local perfusions of 1 microM cPGI2 or 1 microM Iso led to reversible decreases of the O/I ratio that were similar to the decrease induced by the vasodilating reference drug hydralazine (Hydra, 630 microM). Interestingly, a continuous perfusion of Hydra at a submaximal vasodilating concentration (63 microM) was sufficient to prevent further vasodilatation induced by Iso or cPGI2. To take advantage of this observation, experiments were designed to evaluate the influence of the vasodilating effect of Iso or cPGI2 on the ability of either to induce lipolysis in vivo. The results showed that the vasodilating effect of Iso could contribute to glycerol removal from the extracellular fluid and demonstrate that cPGI2 was devoid of lipolytic activity.
利用原位微透析技术,通过测量透析液(流出液)中0.2%乙醇与灌注液(流入液)中0.2%乙醇的分布比例(O/I比率),研究了β-肾上腺素能受体激动剂异丙肾上腺素(Iso)和脂肪组织中花生四烯酸主要代谢产物的稳定类似物卡前列环素(cPGI2)对大鼠附睾周围脂肪垫血流的影响。局部灌注1μM cPGI2或1μM Iso会导致O/I比率可逆性降低,这与血管舒张参考药物肼屈嗪(Hydra,630μM)引起的降低相似。有趣的是,以亚最大血管舒张浓度(63μM)持续灌注Hydra足以防止Iso或cPGI2诱导的进一步血管舒张。为利用这一观察结果,设计实验评估Iso或cPGI2的血管舒张作用对其在体内诱导脂解能力的影响。结果表明,Iso的血管舒张作用有助于从细胞外液中清除甘油,并表明cPGI2没有脂解活性。